Evidence map›Paper›PMID 34910170›Full record

ArticleClinical infectious diseases : an official publication of the Infectious Diseases Society of America2021

Building Capacity and Infrastructure at Hospitals Implementing Minimally Invasive Tissue Sampling: Experience and Lessons Learned From Nepal, Rwanda, and Tanzania.

Nuwadatta Subedi, Suraj Bhattarai, Alex Mremi, Gervais Ntakirutimana, Marie Claire Ndayisaba, Belson Rugwizangoga, Djibril Mbarushimana, Elisée Hategekimana, Vestine Tuyizere, Christina Paganelli

Open access · hybridAbstract read
In one paragraph

Article in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.6field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Observational
  2. Article
  3. Article
  4. Minimally Invasive Tissue Sampling Surveillance Alliance-Facilitating the Expansion of Pathology-Based Mortality Surveillance.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 4 countries.

Nuwadatta SubediGandaki Medical College Teaching Hospital and Research Center, Gandaki Province, Pokhara, Nepal.ORCID 0000-0003-2233-1196
Suraj BhattaraiGandaki Medical College Teaching Hospital and Research Center, Gandaki Province, Pokhara, Nepal.
Alex MremiDepartment of Pathology, Kilimanjaro Christian Medical Centre and Kilimanjaro Christian Medical University College, Moshi, Tanzania.
Gervais Ntakirutimana(CHUK), Kigali, Rwanda.
Marie Claire Ndayisaba(CHUK), Kigali, Rwanda.
Belson Rugwizangoga(CHUK), Kigali, Rwanda.
Djibril MbarushimanaCentre Hospitalier Universitaire de Butare (CHUB), Huye, Rwanda.
Elisée HategekimanaCentre Hospitalier Universitaire de Butare (CHUB), Huye, Rwanda.
Vestine TuyizereCentre Hospitalier Universitaire de Butare (CHUB), Huye, Rwanda.
Christina PaganelliResearch Triangle Institute (RTI) International, Seattle, Washington, USA.
Centre Hospitalier Universitaire de Kigali · RWUniversity Teaching Hospital of Butare · RWNepal Medical College Teaching Hospital · NPKilimanjaro Christian Medical Centre · TZRTI International · US

Funding

Bill and Melinda Gates Foundation OPP1180554
6 · The paper itself

Abstract

backgroundMinimally invasive tissue sampling (MITS) is a useful tool to determine cause of death in low- and middle-income countries (LMICs). In 2019 the MITS Surveillance Alliance supported the implementation of small-scale postmortem studies using MITS in several LMICs.

methodsIn this article we describe the preparations, challenges, and lessons learned as part of implementing MITS across 4 study sites in 3 countries: Nepal, Rwanda, and Tanzania. We describe the process for building capacity to conduct MITS, which consisted of training in MITS sample collection, individual site assessment to determine readiness and gaps prior to implementation, site visits as sites began implementation of MITS, and feedback based on remote evaluation of histology slides via an online portal.

resultsThe 4 study sites each conducted 100 MITS, for a total of 400. All 4 sites lacked sufficient infrastructure and facilities to conduct MITS, and upgrades were required. Common challenges faced by sites included that clinical autopsies were neither routinely conducted nor widely accepted. Limited clinical records made cause of death determination more difficult. Lessons learned included the importance of sensitization of the community and medical staff to MITS to enhance understanding and increase consent.

conclusionsThe study sites accomplished MITS and utilized the available support systems to overcome the challenges. The quality of the procedures was satisfactory and was facilitated through the organized capacity-building programs.

Indexed as

Capacity BuildingHospitalsCause of DeathHumansNepalRwandaTanzaniaautopsycause of deathlow- and middle-income countriesminimally invasive tissue samplingmortality surveillance

Identifiers

PMID34910170
PMCPMC8672746
OpenAlexW4200462486

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.